Evidence map›Paper›PMID 39731097›Full record

ArticleBMC infectious diseases2024

Choline metabolism modulates cyclic-di-GMP signaling and virulence of Pseudomonas aeruginosa in a macrophage infection model.

Yachun Zhou, Yu Zhang, Xiangke Duan, Tian Zhou, Anmin Ren, Yinyue Deng, Lin Zhong, Lei Liu, Yingfeng Huang, Weidong Zheng and 2 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Simulated microgravity induces time-dependent enhancement ofCurrent research in microbial sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yachun Zhou *Shenzhen Third People's Hospital, National Clinical Research Centre for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China.
Yu Zhang *Department of Pathogen Biology, International Cancer Centre, Base for International Science and Technology Cooperation: Carson Cancer Stem Cell Vaccines R&D Centre, Shenzhen University Health Science Centre, Shenzhen, 518055, China.
Xiangke DuanShenzhen Third People's Hospital, National Clinical Research Centre for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China.
Tian ZhouSchool of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Anmin RenSchool of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Yinyue DengSchool of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, Guangdong, China.
Lin ZhongShenzhen Third People's Hospital, National Clinical Research Centre for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China.
Lei LiuShenzhen Third People's Hospital, National Clinical Research Centre for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China.
Yingfeng HuangDepartment of Laboratory Medicine, Shenzhen University General Hospital, Shenzhen, 518000, China.
Weidong ZhengDepartment of Laboratory Medicine, Shenzhen University General Hospital, Shenzhen, 518000, China.
Dongjing LiuShenzhen Third People's Hospital, National Clinical Research Centre for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China. dangban-ldj@szsy.sustech.edu.cn.
Liang YangShenzhen Third People's Hospital, National Clinical Research Centre for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China. yangl@sustech.edu.cn.

Funding

Guangdong Basic and Applied Basic Research Foundation 2019A1515110640Guangdong High-level Personnel of Special Support Program 2019QN01Y163HaiYa Young Scientist Foundation of Shenzhen University General Hospital 2024-HY013National Natural Science Foundation of China 91951204Shenzhen Science and Technology Program KQTD20200909113758004
6 · The paper itself

Abstract

backgroundBacterial pathogens frequently encounter host-derived metabolites during their colonization and invasion processes, which can serve as nutrients, antimicrobial agents, or signaling molecules for the pathogens. The essential nutrient choline (Cho) is widely known to be utilized by a diverse range of bacteria and may undergo conversion into the disease-associated metabolite trimethylamine (TMA). However, the impact of choline metabolism on bacterial physiology and virulence remains largely unexplored.

methodsHere, we employed an in vitro infection model to investigate the role of Cho in intracellular survival and virulence of Pseudomonas aeruginosa (P. aeruginosa). Additionally, a comprehensive RNA-seq based transcriptomic analysis and various phenotypic assays were performed to elucidate the impacts of Cho on P. aeruginosa.

resultsWe observed that the Cho metabolite glycine betaine (GB) effectively reduced intracellular levels of cyclic-di-GMP (c-di-GMP). Supplementation of Cho or GB in P. aeruginosa had thus affected c-di-GMP regulated phenotypes, such as pyoverdine production, biofilm formation, and mobility. Depletion of Cho metabolism through knockout of the betAB operon resulted in compromised intracellular survival of P. aeruginosa. Notably, the P. aeruginosa betAB mutant elicited a more robust protective inflammatory response compared to the wild-type strain.

conclusionOur study showed that P. aeruginosa Cho metabolism not only interferes host nutritional immunity, but also directly affect multiple virulence phenotypes through modulation of c-di-GMP signaling.

Indexed as

BetaineBiofilmsCholineCyclic GMPMacrophagesPseudomonas aeruginosaSignal TransductionAnimalsGene Expression Regulation, BacterialMicePseudomonas InfectionsRAW 264.7 CellsVirulenceBetainebis(3',5')-cyclic diguanylic acidCholineCyclic GMPBiofilmCholine metabolismCyclic-di-GMPPseudomonas aeruginosaVirulence

Identifiers

PMID39731097
PMCPMC11681757

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.